GNCA Gross Margin

The Gross Margin of Genocea Biosciences Inc (GNCA) is N/A.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

GNCA Gross Margin - Peers Comparison

Ticker	Name	Value
950220.KQ	Neoimmunetech Inc	7775.20%
BBLG	Bone Biologics Corp	7775.20%
IPIX	Innovation Pharmaceuticals Inc	100.00%
ABBV	Abbvie Inc	69.99%
ARMP	Armata Pharmaceuticals Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.11%
GTBP	GT Biopharma Inc	100.00%
REGN	Regeneron Pharmaceuticals Inc	87.01%
SVRA	Savara Inc	100.00%
950200.KQ	Psomagen Inc	23.13%
CFRX	ContraFect Corp	7775.20%
ELDN	Eledon Pharmaceuticals Inc	7775.20%
CYTR	CytRx Corp	100.00%
LMNL	Liminal BioSciences Inc	38.55%
SIOX	Sio Gene Therapies Inc	7775.20%
VTVT	vTv Therapeutics Inc	7775.20%
AMGN	Amgen Inc	61.53%
APM	Aptorum Group Ltd	2.45%
GILD	Gilead Sciences Inc	78.26%
LOGC	LogicBio Therapeutics Inc	16.28%
CTIC	CTI Biopharma Corp	93.49%
EQ	Equillium Inc	7775.20%
MRNA	Moderna Inc	70.06%
OGEN	Oragenics Inc	60.64%
AIM	AIM ImmunoTech Inc	79.21%
CLSN	Celsion Corp	16.33%
EDT.TO	Spectral Medical Inc	44.53%
MBRX	Moleculin Biotech Inc	7775.20%
ISR	IsoRay Inc	23.01%
950160.KQ	Kolon TissueGene Inc	11.72%
CAPR	Capricor Therapeutics Inc	7775.20%
CLRB	Cellectar Biosciences Inc	7775.20%
GALT	Galectin Therapeutics Inc	7775.20%